Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Alberto Papi,Bradley E. Chipps,Richard Beasley,Reynold A. Panettieri,Elliot Israel, Mark Cooper, Lynn Dunsire, Allison Jeynes-Ellis,Robert Rees,Frank C. Albers,Christy Cappelletti

Therapeutic Advances in Respiratory Disease（2024）

引用 0|浏览0

暂无评分

摘要

What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要